Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada flag Canada · Delayed Price · Currency is CAD
11.33
0.00 (0.00%)
Jun 4, 2025, 9:30 AM EDT

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $8.75M USD in the quarter ending March 31, 2025, a decrease of -65.52%. This brings the company's revenue in the last twelve months to $30.91M, down -31.23% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.

Revenue (ttm)
$30.91M
Revenue Growth
-31.23%
P/S Ratio
6.53
Revenue / Employee
$966.00K
Employees
32
Market Cap
290.00M CAD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1,284.50%
Dec 31, 20221.54M--
Dec 31, 2021---
Dec 31, 2020170.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition